CSII - Cardiovascular Systems Inc.

CSII Stock Chart

CSII Profile

Cardiovascular Systems, Inc., headquartered in Saint Paul, Minnesota, is a pioneering medical technology company specializing in the development and global commercialization of innovative solutions for treating peripheral and coronary artery diseases. Established in 1989, the company focuses on advancing catheter-based platforms designed to address various plaque types found in arteries above and below the knee, including calcified plaque, which poses challenges for traditional surgical, catheter, and pharmacological treatments.

The company's product portfolio includes a range of peripheral artery disease solutions, alongside peripheral support products aimed at enhancing patient outcomes and quality of life. Cardiovascular Systems, Inc. also offers the Diamondback 360 Coronary orbital atherectomy systems (OAS), a cutting-edge product for treating coronary artery disease (CAD) by facilitating effective stent delivery in patients with severely calcified coronary artery lesions.

In addition to its core offerings, Cardiovascular Systems, Inc. provides a comprehensive array of ancillary products such as guidewires, catheters, balloons, embolic protection systems, and other OAS support products. The company collaborates with industry partners, including a strategic alliance with Chansu Vascular Technologies, LLC, focused on developing novel peripheral and coronary everolimus drug-coated balloons to further advance treatment options for patients.

With its commitment to innovation and improving patient outcomes, Cardiovascular Systems, Inc. continues to expand its global footprint, leveraging its expertise in medical technology to meet the evolving needs of healthcare professionals and patients worldwide.

CSII Revenue Chart

CSII Earnings

Analyst Ratings